Canada Gabapentin Market Size & Outlook, 2025-2030
Related Markets
Canada gabapentin market highlights
- The Canada gabapentin market generated a revenue of USD 49.4 million in 2024 and is expected to reach USD 58.2 million by 2030.
- The Canada market is expected to grow at a CAGR of 2.2% from 2025 to 2030.
- In terms of segment, capsule was the largest revenue generating dosage form in 2024.
- Tablet is the most lucrative dosage form segment registering the fastest growth during the forecast period.
Gabapentin market data book summary
| Market revenue in 2024 | USD 49.4 million |
| Market revenue in 2030 | USD 58.2 million |
| Growth rate | 2.2% (CAGR from 2025 to 2030) |
| Largest segment | Capsule |
| Fastest growing segment | Tablet |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Tablet, Capsule, Oral Solution |
| Key market players worldwide | Zydus Lifesciences, Glenmark Pharmaceuticals, Sun Pharmaceutical Industries, Ascendis Pharma, Apotex Inc., Teva Pharmaceutical Industries Ltd, Aurobindo Pharma, Amneal Pharmaceuticals, Cipla Ltd DR, Assertio Holdings Inc, Arbor Pharmaceuticals, Pfizer Inc |
Other key industry trends
- In terms of revenue, Canada accounted for 2.2% of the global gabapentin market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. gabapentin market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 872.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Gabapentin Market Scope
Gabapentin Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Ascendis Pharma | View profile | 501-1000 | Palo Alto, California, United States, North America | http://ascendispharma.com |
| Assertio Holdings Inc | View profile | 30 | 100 South Saunders Road, Suite 300, Lake Forest, IL, United States, 60045 | https://www.assertiotx.com |
| Glenmark Pharmaceuticals | View profile | 10001+ | Andheri, Maharashtra, India, Asia | http://www.glenmarkpharma.com |
| Apotex Inc. | View profile | 10001+ | Toronto, Ontario, Canada, North America | http://www.apotex.com |
| Amneal Pharmaceuticals | View profile | 5001-10000 | Bridgewater, New Jersey, United States, North America | http://amneal.com/ |
| Arbor Pharmaceuticals | View profile | 501-1000 | Atlanta, Georgia, United States, North America | http://www.arborpharma.com |
| Zydus Lifesciences | View profile | 10001+ | Ahmedabad, Gujarat, India, Asia | https://zyduslife.com/ |
| Sun Pharmaceutical Industries | View profile | 10001+ | Mumbai, Maharashtra, India, Asia | http://www.sunpharma.com |
| Aurobindo Pharma | View profile | 10001+ | Hyderabad, Andhra Pradesh, India, Asia | http://aurobindo.com |
| Cipla Ltd DR | View profile | 38955 | Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, India, 400 013 | https://www.cipla.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
Canada gabapentin market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gabapentin market will help companies and investors design strategic landscapes.
Capsule was the largest segment with a revenue share of 58.7% in 2024. Horizon Databook has segmented the Canada gabapentin market based on tablet, capsule, oral solution covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Canada gabapentin market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Canada gabapentin market databook
-
Our clientele includes a mix of gabapentin market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada gabapentin market , including forecasts for subscribers. This country databook contains high-level insights into Canada gabapentin market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Canada gabapentin market size, by dosage form, 2018-2030 (US$M)
Canada Gabapentin Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
